Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14529666rdf:typepubmed:Citationlld:pubmed
pubmed-article:14529666lifeskim:mentionsumls-concept:C0206558lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C1140680lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C0521026lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C1522424lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C0596988lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:14529666lifeskim:mentionsumls-concept:C1518581lld:lifeskim
pubmed-article:14529666pubmed:issue1lld:pubmed
pubmed-article:14529666pubmed:dateCreated2003-10-7lld:pubmed
pubmed-article:14529666pubmed:abstractTextAttenuated mutant strains of herpes simplex virus (HSV) have been effectively used for treatment of malignant brain tumors. As HSV-1 can infect and lyse a variety of cell types, other malignancies may also benefit from such treatment. We sought to test the feasibility of HSV-1 mutant-mediated gene therapy treatment of ovarian cancer.lld:pubmed
pubmed-article:14529666pubmed:languageenglld:pubmed
pubmed-article:14529666pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14529666pubmed:citationSubsetIMlld:pubmed
pubmed-article:14529666pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14529666pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14529666pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14529666pubmed:statusMEDLINElld:pubmed
pubmed-article:14529666pubmed:monthOctlld:pubmed
pubmed-article:14529666pubmed:issn0090-8258lld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:NishiyamaYuki...lld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:NagasakaTetsu...lld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:KikkawaFumita...lld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:KuzuyaKazuoKlld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:GoshimaFumiFlld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:NakanishiToru...lld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:NozawaNaokiNlld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:NawaAkihiroAlld:pubmed
pubmed-article:14529666pubmed:authorpubmed-author:NiwaYoshimits...lld:pubmed
pubmed-article:14529666pubmed:issnTypePrintlld:pubmed
pubmed-article:14529666pubmed:volume91lld:pubmed
pubmed-article:14529666pubmed:ownerNLMlld:pubmed
pubmed-article:14529666pubmed:authorsCompleteYlld:pubmed
pubmed-article:14529666pubmed:pagination81-8lld:pubmed
pubmed-article:14529666pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:meshHeadingpubmed-meshheading:14529666...lld:pubmed
pubmed-article:14529666pubmed:year2003lld:pubmed
pubmed-article:14529666pubmed:articleTitleOncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model.lld:pubmed
pubmed-article:14529666pubmed:affiliationDepartment of Gynecology, Aichi Cancer Center Hospital, 1-1 kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. nawa2000@aichi-cc.jplld:pubmed
pubmed-article:14529666pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14529666pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14529666lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14529666lld:pubmed